Price to Sales (P/S)
since 2005
Paying user area
Try for free
Humana Inc. pages available for free this week:
- Statement of Comprehensive Income
- Balance Sheet: Assets
- Balance Sheet: Liabilities and Stockholders’ Equity
- Cash Flow Statement
- Analysis of Solvency Ratios
- Analysis of Reportable Segments
- Enterprise Value (EV)
- Price to FCFE (P/FCFE)
- Total Asset Turnover since 2005
- Price to Operating Profit (P/OP) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Humana Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Humana Inc., P/S, long-term trends, calculation
| P/S | = | Share price1, 2, 3 | ÷ | Sales per share1 | Sales per share1 | = | External revenues1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2024 | = | ÷ | = | ÷ | |||||||
| Feb 16, 2023 | = | ÷ | = | ÷ | |||||||
| Feb 17, 2022 | = | ÷ | = | ÷ | |||||||
| Feb 18, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 20, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 16, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 17, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 18, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 18, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2014 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2013 | = | ÷ | = | ÷ | |||||||
| Feb 24, 2012 | = | ÷ | = | ÷ | |||||||
| Feb 18, 2011 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2010 | = | ÷ | = | ÷ | |||||||
| Feb 20, 2009 | = | ÷ | = | ÷ | |||||||
| Feb 25, 2008 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2007 | = | ÷ | = | ÷ | |||||||
| Mar 3, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Humana Inc. Annual Report.
The analysis of the financial data reveals several key trends over the examined periods.
- Share Price
- The share price exhibits a generally upward trend from 50.86 US$ in 2006, reaching a peak of 505.69 US$ in early 2023. There are notable fluctuations, including a significant dip in 2009 to 40.54 US$, likely reflecting external economic conditions during that period. Following this, the share price recovered and showed strong growth, surpassing previous highs in subsequent years until a decline to 363.98 US$ in early 2024.
- Sales per Share
- Sales per share increase consistently throughout the entire period, starting from 87.32 US$ in 2006 and rising steadily to 872.79 US$ by 2024. This continuous growth indicates improving operational performance and expansion in revenue generation per share over the years without significant interruptions or declines.
- Price-to-Sales Ratio (P/S)
- The P/S ratio shows variability with an initial decline from 0.58 in 2006 to a low of 0.24 in 2009, paralleling the drop in share price. Post-2009, the ratio gradually improves and peaks at 0.76 in 2020, reflecting stronger investor confidence and valuation relative to sales. However, it declines sharply afterward, falling to 0.42 by 2024, which may indicate a correction in market valuation or increasing sales outpacing share price growth.
Overall, the steady growth in sales per share suggests robust operational performance and market demand. Although the share price has shown significant appreciation over the long term, recent price fluctuations and the decreasing P/S ratio in the last year suggest a potential reevaluation by investors or market volatility. The data indicates strong fundamentals but also highlights the need for attention to market sentiment and valuation metrics going forward.
Comparison to Competitors
Humana Inc., P/S, long-term trends, comparison to competitors
| Humana Inc. | Abbott Laboratories | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|---|
| Feb 15, 2024 | |||||||
| Feb 16, 2023 | |||||||
| Feb 17, 2022 | |||||||
| Feb 18, 2021 | |||||||
| Feb 20, 2020 | |||||||
| Feb 21, 2019 | |||||||
| Feb 16, 2018 | |||||||
| Feb 17, 2017 | |||||||
| Feb 18, 2016 | |||||||
| Feb 18, 2015 | |||||||
| Feb 19, 2014 | |||||||
| Feb 22, 2013 | |||||||
| Feb 24, 2012 | |||||||
| Feb 18, 2011 | |||||||
| Feb 19, 2010 | |||||||
| Feb 20, 2009 | |||||||
| Feb 25, 2008 | |||||||
| Feb 23, 2007 | |||||||
| Mar 3, 2006 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Humana Inc., P/S, long-term trends, comparison to sector (health care equipment & services)
| Humana Inc. | Health Care Equipment & Services | |
|---|---|---|
| Feb 15, 2024 | ||
| Feb 16, 2023 | ||
| Feb 17, 2022 | ||
| Feb 18, 2021 | ||
| Feb 20, 2020 | ||
| Feb 21, 2019 | ||
| Feb 16, 2018 | ||
| Feb 17, 2017 | ||
| Feb 18, 2016 | ||
| Feb 18, 2015 | ||
| Feb 19, 2014 | ||
| Feb 22, 2013 | ||
| Feb 24, 2012 | ||
| Feb 18, 2011 | ||
| Feb 19, 2010 | ||
| Feb 20, 2009 | ||
| Feb 25, 2008 | ||
| Feb 23, 2007 | ||
| Mar 3, 2006 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Humana Inc., P/S, long-term trends, comparison to industry (health care)
| Humana Inc. | Health Care | |
|---|---|---|
| Feb 15, 2024 | ||
| Feb 16, 2023 | ||
| Feb 17, 2022 | ||
| Feb 18, 2021 | ||
| Feb 20, 2020 | ||
| Feb 21, 2019 | ||
| Feb 16, 2018 | ||
| Feb 17, 2017 | ||
| Feb 18, 2016 | ||
| Feb 18, 2015 | ||
| Feb 19, 2014 | ||
| Feb 22, 2013 | ||
| Feb 24, 2012 | ||
| Feb 18, 2011 | ||
| Feb 19, 2010 | ||
| Feb 20, 2009 | ||
| Feb 25, 2008 | ||
| Feb 23, 2007 | ||
| Mar 3, 2006 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).